American Capital Advisory’s Insmed INSM Stock Holding History

American Capital Advisory’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$747	Buy	7 +1	+17%	+$121	﹤0.01%	869
2026 Q1	$982	Sell	6 -1	-14%	-$154	﹤0.01%	691
2025 Q4	$1.22K	Buy	7 +2	+40%	+$365	﹤0.01%	555
2025 Q3	$721	Hold	5	–	–	﹤0.01%	608
2025 Q2	$504	Buy	+5	New	+$382	﹤0.01%	631

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

American Capital Advisory's INSM Position: Q2 2026 in Review

American Capital Advisory increased its Insmed (INSM) stake by 17% in Q2 2026, buying an estimated $121 and bringing the position to 7 shares worth $747. The position accounts for ﹤0.01% of the portfolio, ranked #869.

American Capital Advisory first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.22K in Q4 2025. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

American Capital Advisory held 7 shares of Insmed worth $747 as of Q2 2026.
American Capital Advisory bought 1 Insmed share in Q2 2026, an estimated $121.
Insmed made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #869 holding.
American Capital Advisory first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
American Capital Advisory's Insmed position peaked at $1.22K in Q4 2025.
281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.